Table 2.
Patient Characteristics for Stool Study
Cases N = 19 |
Controls N = 35 |
|
---|---|---|
CUC | 17 | 25 |
Crohn’s disease | 2 | 10 |
% Male | 63 | 63 |
Median age, years (range) | 60 (45–72) | 60 (45–77) |
Median IBD duration, years (range) | 30 (2–50) | 14 (0–45) 1 |
Extensive (%)2 | 17 (89) | 19 (54)3 |
IBD Activity4 | ||
Inactive (%) | 8 (42) | 12 (38) |
Mild (%) | 9 (45) | 11 (34) |
Moderate (%) | 1 (5) | 3 (9) |
Severe (%) | 1 (5) | 6 (19) |
PSC (%) | 4 (21) | 5 (16) |
p=0.0008
Inflammation proximal to splenic flexure
p=0.01
Disease activity could not be confirmed for 3 control patients
CUC, chronic ulcerative colitis; IBD, inflammatory bowel disease; PSC, primary sclerosing cholangitis.
Cases = IBD with colorectal neoplasia, Controls = IBD without neoplasia